Group 1 - The 2025 China International Service Trade Fair will be held from September 10 to 14, focusing on health and wellness services with the theme "Smart Leading Future, Healthy Life" [1] - The health and wellness service section will feature two main display experience areas: "Smart Therapy Cloud Matrix" and "National Health Service Matrix" [1] - Major global companies such as Elsevier and GE Healthcare will participate, with a participation rate of 54% from Fortune 500 companies and 53% internationalization rate [1] Group 2 - The Health Priority Zone will showcase innovative projects from local medical institutions, focusing on the integration of medical and elderly care services [2] - A record 48 traditional Chinese medicine institutions will participate, with 27 offline, highlighting the modernization and international potential of traditional Chinese medicine [2] - The Capital International Medical Conference will take place during the trade fair, discussing technology innovation and the development of the medical and health industry [3]

Core Viewpoint - The collaboration between Jinan University and Zhongjing Wanshi Pharmaceutical aims to conduct clinical research on age-related degenerative diseases, leveraging traditional Chinese medicine (TCM) to address conditions such as osteoporosis, knee osteoarthritis, and Alzheimer's disease, particularly focusing on the concept of kidney deficiency [4][6]. Group 1: Event Overview - The signing ceremony for the clinical research project was held on April 29, organized by Jinan University and attended by various experts and scholars from Guangdong [2]. - Key representatives included Zhang Ronghua, Vice President of Jinan University, and Ma Yun, Deputy General Manager of Zhongjing Wanshi Pharmaceutical, who signed the cooperation agreement [6]. Group 2: Research Focus - The project will explore the pathological mechanisms and key targets of age-related degenerative diseases, emphasizing the role of kidney deficiency in these conditions [6]. - The research aims to innovate TCM applications, particularly the modern use of classic formulas like Zuo Gui Wan and You Gui Wan, in treating kidney deficiency-related diseases [4][6]. Group 3: Collaborative Goals - The collaboration seeks to integrate multidisciplinary approaches to enhance the understanding and treatment of age-related diseases through TCM [6]. - Zhongjing Wanshi Pharmaceutical emphasizes the importance of high-quality medicinal materials and aims to explore new treatment pathways that combine TCM and Western medicine [6].